CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (USD $)	3 Months Ended				6 Months Ended
	Jun. 30, 2014		Jun. 30, 2013		Jun. 30, 2014		Jun. 30, 2013
REVENUE:
Dental practice revenue	$ 15,571,178		$ 15,012,532		$ 31,043,913		$ 30,175,979
Capitation revenue	1,305,345		1,423,760		2,639,008		2,864,617
Total Revenue	16,876,523		16,436,292		33,682,921		33,040,596
DIRECT EXPENSES:
Clinical salaries and benefits	9,934,075		9,693,407		19,827,441		19,405,946
Dental supplies	761,999		731,596		1,453,692		1,438,245
Laboratory fees	892,775		798,331		1,696,778		1,558,708
Occupancy	1,459,529		1,453,961		2,917,923		2,911,538
Advertising and marketing	239,324		215,408		469,249		578,237
Depreciation and amortization	1,026,816		838,363		1,994,079		1,658,244
General and administrative	1,395,000		1,056,742		2,824,904		2,267,645
Total Direct Expenses	15,709,518		14,787,808		31,184,066		29,818,563
Contribution from dental offices	1,167,005		1,648,484		2,498,855		3,222,033
CORPORATE EXPENSES:
General and administrative	1,179,881	[1]	1,297,830	[1]	2,349,025	[2]	2,402,819	[2]
Depreciation and amortization	56,655		49,497		111,294		95,750
OPERATING INCOME/(LOSS)	(69,531)		301,157		38,536		723,464
Interest expense, net	27,584		6,798		54,778		33,513
INCOME/(LOSS) BEFORE INCOME TAXES	(97,115)		294,359		(16,242)		689,951
Income tax expense/(benefit)	(37,874)		114,799		(6,334)		269,081
NET INCOME/(LOSS)	$ (59,241)		$ 179,560		$ (9,908)		$ 420,870
Net income/(loss) per share of Common Stock - Basic (in dollars per share)	$ (0.03)		$ 0.10		$ (0.01)		$ 0.23
Net income/(loss) per share of Common Stock - Diluted (in dollars per share)	$ (0.03)		$ 0.10		$ (0.01)		$ 0.23
Cash dividends per share of Common Stock (in dollars per share)	$ 0.22		$ 0.22		$ 0.44		$ 0.44
Weighted average number of shares of Common Stock and dilutive securities:
Basic (in shares)	1,860,089		1,851,598		1,857,288		1,849,118
Diluted (in shares)	1,860,089		1,863,855		1,857,288		1,861,020

[1] Corporate expense - general and administrative includes $106,573 of stock-based compensation expense pursuant to ASC Topic 718 for the quarter ended June 30, 2013 and $69,606 of stock-based compensation expense pursuant to ASC Topic 718 for the quarter ended June 30, 2014.

[2] Corporate expense - general and administrative includes $237,581 of stock-based compensation expense pursuant to ASC Topic 718 for the six months ended June 30, 2013 and $170,035 of stock-based compensation expense pursuant to ASC Topic 718 for the six months ended June 30, 2014.